Assessment of the scope, completeness, and consistency of various drug information resources related to COVID-19 medications in pregnancy and lactationarticle Published on 2023-04-272024-09-05 Journal: BMC Pregnancy and Childbirth [Category] update2024, [키워드] Consistency Evidence-based information Fetal risk medication information teratogenicity treatment guidelines [DOI] 10.1186/s12884-023-05609-2 PMC 바로가기 [Article Type] article
Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis BReview Published on 2023-01-012023-06-13 Journal: Digestive diseases (Basel, Switzerland) [Category] B형 간염, [키워드] antiviral therapy Hepatocellular carcinoma Liver cirrhosis treatment guidelines [DOI] 10.1159/000526933 PMC 바로가기 [Article Type] Review
Neuropsychiatric manifestation of the drugs used in the treatment of SARS-2-CoV-2019 (COVID-19) infection and their management: An overview and practice implicationsSARS-2-CoV-2019(COVID-19) 감염 치료에 사용되는 약물의 신경정신병적 발현 및 그 관리: 개요 및 실행 의미Review Published on 2022-07-012022-09-11 Journal: Asian journal of psychiatry [Category] COVID19(2023년), SARS, 변종, 치료법, 치료제, [키워드] Adverse adverse effect Adverse reaction Affect Anti-COVID-19 medications complicate complications consequence COVID COVID-19 COVID-19 treatment dose drug drug-drug interaction drugs hcp Healthcare professional healthcare professionals help highlight implication Infection lAbel management manifestation medication medications myriad Neuropsychiatric off-label off-label use physical Primary infection Prognosis review risk factor Risk factors SARS-2-CoV-2019. Symptom Symptoms Topic Treatment treatment guideline treatment guidelines variant virulence virus [DOI] 10.1016/j.ajp.2022.103101 PMC 바로가기 [Article Type] Review
Overview of sleep management during COVID-19Review article Published on 2022-03-012022-10-05 Journal: Sleep medicine [Category] SARS, 신약개발, [키워드] affected Anxiety CBT cognitive Controlled trial COVID-19 COVID-19 infection COVID-19 pandemic described Disordered dysfunction Efficacy expected fatigue greater groups health care workers IMPROVE include Infection Insomnia Intervention management mental health pandemic Population prevalence rate problems public health Public health model of sleep management question recognizing reported Research sleep disorders Sleep disturbance Sleep vital sign suffered Symptom therapy Treatment treatment guideline treatment guidelines Treatment strategies [DOI] 10.1016/j.sleep.2021.04.024 [Article Type] Review article
Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine초기 CovID-19 Pandemic 동안 입원 환자를위한 용도로 된 약물에 대한 치료 지침에 대한 임상 증거 : 코르티코 스테로이드, 항응고제, (Hydroxy) 클로로퀸Review Published on 2022-02-182022-08-31 Journal: Frontiers in Public Health [Category] COVID19(2023년), meta-analysis, SARS, 임상, [키워드] adoption Analysis Anticoagulants best Chloroquine clinical Clinical data clinical evidence Clinical studies clinical study clinical trials Coagulopathy competing conducted coronavirus disease Coronavirus disease 2019 Corticosteroids COVID-19 drug Efficacy and safety evaluated Evidence evidence generation Factor Factors Germany guideline Health Organization hospital hospitalized COVID-19 patient hospitalized COVID-19 patients hydroxy identify incorporation Inflammation Informing International meta-analyses Meta-analysis MOST National national treatment observational studies pandemic Patient care platform Platform trial platform trials protocol provided question randomized clinical trial RCT RCTs recommendations referred to Repurposed drug Repurposed drugs researcher Result retrospective cohort retrospective cohort study robust scientific rigor severely ill patient severely ill patients Spread Treatment treatment guideline treatment guidelines trials United State United States Viral viral replication WHO World Health Organization [DOI] 10.3389/fpubh.2022.804404 PMC 바로가기 [Article Type] Review
Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelinesArticle Published on 2021-12-012023-06-13 Journal: Hepatology international [Category] B형 간염, [키워드] antiviral therapy Benefits family history gray zone Hepatitis B virus Hepatocellular carcinoma Noncirrhosis prediction risk score treatment guidelines [DOI] 10.1007/s12072-021-10263-x
A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients간이식 소아 환자의 COVID-19 질병 경과 및 관리에 대한 단일 센터 보고서Article Published on 2021-11-012022-09-11 Journal: Pediatric transplantation [Category] SARS, 치료기술, [키워드] absence Allograft Anakinra anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody Antibiotic therapy antibody children Clinical and laboratory data collected COVID-19 COVID-19 diagnosis COVID-19 disease course COVID-19 symptom develop diagnosed disease severity electronic patient record Electronic patient records Everolimus Favipiravir Hyperactivation IL-6 immune system Immunocompromised Immunocompromised patient Immunocompromised patients Immunosuppression increased risk IVIG laboratory data liver liver transplant Liver transplantation lymphopenia management median median age MMF mounted Non-invasive not affect one patient Oxygenation Patient patients PCR positive PCR test Pediatric patient probable COVID-19 retained SARS-CoV-2 serum Serum IL-6 severe COVID-19 symptoms single-center solid organ Stopping Support survival tacrolimus therapy Treatment treatment guideline treatment guidelines virtue were used with COVID-19 written consent X-ray [DOI] 10.1111/petr.14061 PMC 바로가기 [Article Type] Article
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2SARS-COV-2에 대한 인터페론 ALFA-2B 및 조합 Lopinavir/Ritonavir Plus 인터페론 ALFA-2B의 비교 치료 효능Research Article Published on 2021-08-302022-09-10 Journal: BMC Infectious Diseases [Category] SARS, 치료제, [키워드] Adult patients adverse event adverse events antiviral drug antiviral drugs assigned association benefit clearance Clinical characteristics clinical monitoring Combination Comparative confidence interval coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 Cox proportional hazard Cox proportional hazards regression disease Efficacy and safety evaluate faster group incidence individual Infection interferon interferon alfa-2b Lopinavir Lopinavir/ritonavir Nasopharyngeal swab no significant difference no significant differences not significantly different outbreak outcome oxygen oxygen support Patient patients hospitalized patients with SARS-CoV-2 PCR Pneumonia primary endpoint primary endpoints public health required Result retrospective cohort study Ritonavir SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) significant differences standard care group standard supportive care Symptom therapeutic efficacy therapy three group three groups Treatment treatment guideline treatment guidelines triggered virus virus clearance were assessed with COVID-19 [DOI] 10.1186/s12879-021-06595-6 PMC 바로가기 [Article Type] Research Article
Perceptions, risk and understandings of the COVID-19 pandemic in urban South AfricaOriginal Research Published on 2021-06-282022-10-29 Journal: The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa [Category] COVID-19, [키워드] community-based cohort study coronavirus disease COVID-19 COVID-19 pandemic demographic characteristics disease elicited finding Health IMPROVE infection risk knowledge Level lockdown mental health moderate National pandemic participant perceptions Perspective physical predicted Public public health prevention question reduce Regulation Result risk setting severity significantly South South Africa stressors Symptoms the disease treatment guidelines virus [DOI] 10.4102/sajpsychiatry.27i0.1580 PMC 바로가기 [Article Type] Original Research
Characteristics of COVID-19 in cancer patients: a cross-sectional study in PeruResearch Published on 2021-06-102022-10-31 Journal: ecancermedicalscience [Category] COVID-19, [키워드] acute respiratory distress acute respiratory syndrome age Asymptomatic Asymptomatic carrier Cancer Comorbidity conducted coronavirus cough COVID-19 COVID-19 diagnosis cross-sectional D-dimer disease Dyspnoea early diagnosis elevated lactate dehydrogenase evaluated Fatality rate ferritin Fever haematologic malignancy higher risk hospitalised increased mortality Infection information LDH Lung disease lymphopenia male malignancy management Mortality Nosocomial infection outcome paediatric patient paediatric patients Patient patients populations positive Respiratory failure Result Risk factors SARS-CoV-2 severity Symptom syndrome transcriptase Treatment treatment guidelines Tumours variable [DOI] 10.3332/ecancer.2021.1246 PMC 바로가기 [Article Type] Research